Anorganic nutrients Bismuth
Aus coViki
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „ {{tp|p=32516203|t=2020. Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.|pdf=|usr=008}}“) |
|||
(Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) | |||
Zeile 1: | Zeile 1: | ||
− | + | {{up|PHA ImmunoNutrients}} | |
{{tp|p=32516203|t=2020. Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.|pdf=|usr=008}} | {{tp|p=32516203|t=2020. Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.|pdf=|usr=008}} | ||
+ | {{tp|p=32500504|t=2020. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.|pdf=|usr=009}} | ||
+ | {{tp|p=33028965|t=2020. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.|pdf=|usr=020}} |
Aktuelle Version vom 12. April 2021, 17:49 Uhr
PHA ImmunoNutrients |
32516203 2020. Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
32500504 2020. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
33028965 2020. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.